| Monograph Title
|
Monograph Section
|
Scientific Liaison
|
| ALBUTEROL SULFATE PF 34(2) Pg. 242 | USP Reference standards <11> | Kahkashan Zaidi |
| ALBUTEROL SULFATE PF 34(2) Pg. 242 | Assay | Kahkashan Zaidi |
| ALPHA-LACTALBUMIN PF 34(3) Pg. 670 | Microbial limits, <61> | Radha Tirumalai |
| ALUMINUM ACETATE TOPICAL SOLUTION PF 34(2) Pg. 242 | Identification | Behnam Davani |
| ALUMINUM SUBACETATE TOPICAL SOLUTION PF 34(2) Pg. 242 | Identification | Feiwen Mao |
| AMINO METHACRYLATE COPOLYMER PF 34(2) Pg. 326 | Definition | Hong Wang |
| AMINO METHACRYLATE COPOLYMER PF 34(2) Pg. 326 | Packaging and storage | Hong Wang |
| AMINO METHACRYLATE COPOLYMER PF 34(2) Pg. 326 | Viscosity <911> | Hong Wang |
| AMINO METHACRYLATE COPOLYMER PF 34(2) Pg. 326 | Limit of monomers | Hong Wang |
| AMINO METHACRYLATE COPOLYMER PF 34(2) Pg. 326 | Chemical Information | Hong Wang |
| AMODIAQUINE HYDROCHLORIDE PF 34(2) Pg. 243 | USP Reference standards <11> | Behnam Davani |
| AMODIAQUINE HYDROCHLORIDE PF 34(2) Pg. 243 | Identification | Behnam Davani |
| AMODIAQUINE HYDROCHLORIDE PF 34(2) Pg. 243 | Chromatographic purity | Behnam Davani |
| AMODIAQUINE HYDROCHLORIDE PF 34(2) Pg. 243 | Assay | Behnam Davani |
| AMODIAQUINE HYDROCHLORIDE TABLETS PF 34(3) Pg. 558 | USP Reference standards <11> | Behnam Davani |
| AMODIAQUINE HYDROCHLORIDE TABLETS PF 34(3) Pg. 558 | Identification | Behnam Davani |
| AMODIAQUINE HYDROCHLORIDE TABLETS PF 34(3) Pg. 558 | Assay | Behnam Davani |
| ANASTROZOLE PF 34(2) Pg. 244 | Title | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Chemical Info | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Definition | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Packaging and storage | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | USP Reference standards <11> | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Identification | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Water, Method Ic <921> | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Residue on ignition <281> | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Heavy metals, Method II <231> | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Related compounds | Feiwen Mao |
| ANASTROZOLE PF 34(2) Pg. 244 | Assay | Feiwen Mao |
| ATOVAQUONE PF 34(2) Pg. 247 | Assay | Behnam Davani |
| BETAMETHASONE ORAL SOLUTION PF 34(3) Pg. 567 | Packaging and storage | Ahalya Wise |
| BETAMETHASONE ORAL SOLUTION PF 34(3) Pg. 567 | Thin-layer chromatographic identification test <201> | Ahalya Wise |
| BETAMETHASONE ORAL SOLUTION PF 34(3) Pg. 567 | Identification | Ahalya Wise |
| BETAMETHASONE ORAL SOLUTION PF 34(3) Pg. 567 | Microbial limits <61> | Radha Tirumalai |
| BETAMETHASONE ORAL SOLUTION PF 34(3) Pg. 567 | pH <791> | Ahalya Wise |
| BETAMETHASONE ORAL SOLUTION PF 34(3) Pg. 567 | Deliverable volume <698> | Ahalya Wise |
| BETAMETHASONE ORAL SOLUTION PF 34(3) Pg. 567 | Related compounds | Ahalya Wise |
| BETAMETHASONE ORAL SOLUTION PF 34(3) Pg. 567 | Assay | Ahalya Wise |
| BISOPROLOL FUMARATE TABLETS PF 34(3) Pg. 570 | Dissolution <711> | Margareth Marques |
| BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 34(3) Pg. 570 | Related compounds | Ravi Ravichandran |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | Title | Ravi Ravichandran |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | Definition | Ravi Ravichandran |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | Packaging and storage | Ravi Ravichandran |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | USP Reference standards <11> | Ravi Ravichandran |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | Identification | Ravi Ravichandran |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | Dissolution <711> | Margareth Marques |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | Uniformity of dosage units <905> | Ravi Ravichandran |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | Chromatographic purity | Ravi Ravichandran |
| CABERGOLINE TABLETS PF 34(3) Pg. 572 | Assay | Ravi Ravichandran |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Title | Curtis Phinney |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Definition | Curtis Phinney |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Packaging and storage | Curtis Phinney |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Labeling | Curtis Phinney |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Identification | Curtis Phinney |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Microbial enumeration <2021> | Radha Tirumalai |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Absence of specified microorganisms <2022> | Radha Tirumalai |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Disintegration and dissolution <2040> | Natalia Davydova |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Weight variation <2091> | Curtis Phinney |
| CALCIUM CITRATE TABLETS PF 34(2) Pg. 312 | Assay for calcium | Curtis Phinney |
| CEFACLOR CAPSULES PF 34(2) Pg. 248 | Identification | Ahalya Wise |
| CEFACLOR CAPSULES PF 34(2) Pg. 248 | Related compounds | Ahalya Wise |
| CEFACLOR CAPSULES PF 34(2) Pg. 248 | Assay | Ahalya Wise |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Title | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Chemical Info | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Definition | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Packaging and storage | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | USP Reference standards <11> | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Identification | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Loss on drying <731> | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Residue on ignition <281> | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Related compounds | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Limit of p-chloroaniline | Elena Gonikberg |
| CHLORHEXIDINE ACETATE PF 34(3) Pg. 582 | Assay | Elena Gonikberg |
| CHLORHEXIDINE GLUCONATE ORAL RINSE PF 34(2) Pg. 250 | Labeling | Elena Gonikberg |
| CHLORHEXIDINE GLUCONATE ORAL RINSE PF 34(2) Pg. 250 | USP Reference standards <11> | Elena Gonikberg |
| CHLORHEXIDINE GLUCONATE SOLUTION PF 34(2) Pg. 250 | USP Reference standards <11> | Elena Gonikberg |
| CHLORHEXIDINE GLUCONATE SOLUTION PF 34(2) Pg. 250 | Limit of p-chloroaniline | Elena Gonikberg |
| CHLORHEXIDINE GLUCONATE SOLUTION PF 34(2) Pg. 250 | Assay | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Title | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Chemical Info | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Definition | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Packaging and storage | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | USP Reference standards <11> | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Identification | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Loss on drying <731> | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Residue on ignition <281> | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Related compounds | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Limit of p-chloroaniline | Elena Gonikberg |
| CHLORHEXIDINE HYDROCHLORIDE PF 34(3) Pg. 585 | Assay | Elena Gonikberg |
| CHLOROQUINE PHOSPHATE PF 34(2) Pg. 251 | USP Reference standards <11> | Behnam Davani |
| CHLOROQUINE PHOSPHATE PF 34(2) Pg. 251 | Identification | Behnam Davani |
| CHLOROQUINE PHOSPHATE PF 34(2) Pg. 251 | Assay | Behnam Davani |
| CHLOROQUINE PHOSPHATE TABLETS PF 34(3) Pg. 587 | USP Reference standards <11> | Behnam Davani |
| CHLOROQUINE PHOSPHATE TABLETS PF 34(3) Pg. 587 | Identification | Behnam Davani |
| CHLOROQUINE PHOSPHATE TABLETS PF 34(3) Pg. 587 | Assay | Behnam Davani |
| CILOSTAZOL PF 34(3) Pg. 589 | Loss on drying <731> | Sujatha Ramakrishna |
| CILOSTAZOL TABLETS PF 33(3) Pg. 395 | Dissolution <711> | Margareth Marques |
| CISAPRIDE PF 34(2) Pg. 253 | Title | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Chemical Info | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Definition | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Packaging and storage | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | USP Reference standards <11> | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Completeness of solution <641> | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Identification | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Specific rotation <781S> | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Water, Method I <921> | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Residue on ignition <281> | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Chromatographic purity | Elena Gonikberg |
| CISAPRIDE PF 34(2) Pg. 253 | Assay | Elena Gonikberg |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Title | Ravi Ravichandran |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Definition | Ravi Ravichandran |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Packaging and storage | Ravi Ravichandran |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | USP Reference standards <11> | Ravi Ravichandran |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Identification | Ravi Ravichandran |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Disintegration <701> | Margareth Marques |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Dissolution <711> | Margareth Marques |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Uniformity of dosage units <905> | Ravi Ravichandran |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Related compounds | Ravi Ravichandran |
| CLONAZEPAM ORALLY-DISINTEGRATING TABLETS PF 34(2) Pg. 254 | Assay | Ravi Ravichandran |
| CLOZAPINE TABLETS PF 34(3) Pg. 589 | Uniformity of dosage units <905> | Ravi Ravichandran |
